[FG] Tschudin Sutter Sarah
Research Group Sarah Tschudin Sutter
Research Focus
Immunology & Infectious Diseases
Area of Research
Hospital acquired infections, with a focus on transmission of multi drug-resistant pathogens, and infection prevention and control interventions.
Collaborations
Local and national Collaborations
Department of Clinical Bacteriology and Mycology, University Hospital Basel
Cantonal Laboratory of the City of Basel
Department of Biosystems and Engineering Sciences, ETH Zürich
Swiss Society for Infectious Diseases
National Center for Infection Prevention (Swissnoso)
ANRESIS, Swiss Centre for Antibiotic Resistance, Bern
National Centre of Competence in Research NCCR AntiResist
International Collaborations
ESCMID (European Societiy for Clinical Microbiology and Infectious Diseases)
- European Committee of Infection Control (EUCIC)
- Study Group for Nosocomial Infections (ESGNI)
- Study Group for Clostridioides difficile (ESGCD)
Ongoing Research Projects
- Transmission of ESBL-producing Enterobacteriales and their mobile genetic elements - identification of sources by whole genome sequencing (ClinicalTrials.gov Identifier: NCT03465683), Swiss National Science Foundation (SNSF), project NRP 72 (407240_167060)
- Routes of transmission of ESBL-producing Enterobacterales in a tertiary academic care center, Swiss National Science Foundation (SNSF) (320030_19790)
- Epidemiology of Carbapenemase-producing Bacteria in a Swiss Tertiary Care Hospital (ClinicalTrials.gov Identifier: NCT04098133)
- NCCR AntiResist (Phase I and II): New approaches to combat antibiotic-resistant bacteria (51NF40_180541)
- Fecal microbiota transplantation versus vancomycin or fidaxomicin in Clostridioides difficile infection first recurrence (Fender) An interventional, pragmatic, prospective, randomized, controlled trial (ClinicalTrials.gov Identifier: NCT05017766), Swiss National Science Foundation IICT 193065
- Simplifying the World Health Organization (WHO) Protocol for Hand Hygiene (ClinicalTrials.gov Identifier: NCT03588221)